Biotimize
About Us
Leading Biopharmaceutical Innovation in Brazil
Founded to fill a critical gap in biotechnology in the Global South, Biotimize stands out as the first biopharmaceutical CDMO in Brazil. Our integrated approach connects research, industry, and the market, enabling companies of all sizes to develop and manufacture biopharmaceuticals efficiently and accessibly.
Global and Local Impact
By strengthening the Health Economic-Industrial Complex, Biotimize reduces dependence on imports and promotes national sovereignty in biopharmaceuticals and the capacity for local development and production.
Biotimize’s Expertise
- Research & Development: Biotimize's specialized technical team provides comprehensive support for innovative bioprocesses, ensuring effective and customized solutions.
- Integrated CDMO Services: From early development to non-clinical batch production, Biotimize provides a complete platform to ensure the success of your projects.
- State-of-the-Art Infrastructure: With modern facilities and compliance with global standards, Biotimize ensures quality and safety at every stage of the process.
- Sustainable Development: Biotimize invests in workforce training and strengthening biotechnology in Brazil, contributing to a healthier and more sustainable future.
Ecosystem
Democratizing drug development with Biotechnology as a Service.